Effect of Majoon Murmakki in Painful menstruation

Effect of Majoon Murmakki in Usre Tams (Dysmenorrhoea) - A Randomized Standard Controlled Clinical Study

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/04/018446

Enrollment

Registered

2019-04-08

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N946- Dysmenorrhea, unspecified

Interventions

Intervention1: Majoon Murmakki (Commiphora myrrha): 3gm orally Twice a day from 1st day of menses to 5 days for two cycles. Control Intervention1: Mefenamic acid: 500mg twice a day from 1st day of men

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients both unmarried and married between the age group of 18-35 years 2. Patients with regular painful menstrual cycles i.e. 21-35 days with one or more associated symptoms like nausea, vomiting, low backache, diarrhoea, fatigue 3. VAS score > 7

Exclusion criteria

Exclusion criteria: 1. Systemic illness like HTN, DM 2. H/o of Allergic /sensitive to NSAIDs 3. H/o of hormonal treatment last 2 months 4. Lactating women

Design outcomes

Primary

Measure	Time frame
Changes in subjective parameters i.e. To reduce menstrrual painTimepoint: 3 months	—

Secondary

Measure	Time frame
Changes in objective parameters i.e. Improve QoLTimepoint: 3 months	—

Countries

India

Contacts

Public ContactHabiba Suhail

Rajiv Gandhi University of Health Sciences

drtabassum.nium@gmail.com7349074142

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026